Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avicenna Therapeutics
Raleigh, North Carolina, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Avicenna Therapeutics is a biotechnology company focused on developing a novel class of "enhanced NSAIDs" for the treatment of cancer and inflammatory diseases. The company's lead candidate, NBS-1120, is a dual nitric oxide (NO) and hydrogen sulfide (H2S) releasing derivative of aspirin designed to target tumor inflammatory pathways while significantly reducing gastrointestinal toxicity. By leveraging the therapeutic properties of gaseous signaling molecules, Avicenna aims to improve the efficacy and safety profile of traditional anti-inflammatory agents in oncology settings. The company is currently in the pre-clinical stage, with research demonstrating potent anti-cancer activity and protective effects against NSAID-induced gastric injury.
- Therapeutic areas
- OncologyImmunologyGastroenterology
- Modalities
- Small moleculeNitric oxide-releasing therapyHydrogen sulfide-releasing therapy
- Industry
- Biotech
Beyond the preview
Go deeper on Avicenna Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avicenna Therapeutics.